8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cardiovascular205 citations

Mechanisms of magnetic sensing and regulating extracellular electron transfer of electroactive bacteria under magnetic fields

Bioeffects Seen

Zhou H, Xuanyuan X, Lv X, Wang J, Feng K, Chen C, Ma J, Xing D · 2023

Share:

Magnetic fields can enhance the bioelectrochemical performance of electroactive bacteria through alterations in electron transfer mechanisms at the molecular level, with potential applications in magnetic sensors.

Plain English Summary

Summary written for general audiences

This 2023 study examined how magnetic fields affect electroactive bacteria (Geobacter sulfurreducens), specifically their ability to generate electric current through extracellular electron transfer. The researchers found that magnetic field exposure increased electricity generation by 50% and energy efficiency by 22%, with molecular analysis showing upregulation of genes involved in electron transfer processes including cytochrome and pili-related genes.

Why This Matters

Electroactive bacteria like Geobacter sulfurreducens are widely studied for their ability to transfer electrons to external surfaces, a process fundamental to bioelectrochemical systems. This study contributes to understanding how physical stimuli like magnetic fields can modulate bacterial metabolism and electron transfer efficiency.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Zhou H, Xuanyuan X, Lv X, Wang J, Feng K, Chen C, Ma J, Xing D (2023). Mechanisms of magnetic sensing and regulating extracellular electron transfer of electroactive bacteria under magnetic fields.
Show BibTeX
@article{zhou_h_xuanyuan_x_lv_x_wang_j_feng_k_chen_c_ma_j_xing_d_ce4286,
  author = {Zhou H and Xuanyuan X and Lv X and Wang J and Feng K and Chen C and Ma J and Xing D},
  title = {Mechanisms of magnetic sensing and regulating extracellular electron transfer of electroactive bacteria under magnetic fields},
  year = {2023},
  doi = {10.1016/s0140-6736(23)00806-1},
  
}
DOI: 10.1016/s0140-6736(23)00806-1PubMed: 37356761

Quick Questions About This Study

The study included 7,036 stroke patients across 121 hospitals in 10 countries. This large sample size provided strong statistical power to detect meaningful differences in patient outcomes between the care bundle and usual care groups.
The care bundle targeted four key areas: lowering blood pressure below 140 mmHg, controlling blood sugar levels, reducing fever to 37.5°C or below, and reversing blood-thinning medication effects within one hour of treatment.
Patients receiving the care bundle had 14% better odds of good functional recovery compared to usual care. They also experienced 20% fewer serious adverse events, demonstrating both improved outcomes and enhanced safety.
The study included hospitals from nine low- and middle-income countries (Brazil, China, India, Mexico, Nigeria, Pakistan, Peru, Sri Lanka, Vietnam) plus one high-income country (Chile), ensuring diverse healthcare settings were represented.
Researchers tracked patient outcomes for six months after the initial stroke treatment. This follow-up period allowed them to assess long-term functional recovery using the modified Rankin scale, which measures disability levels from no symptoms to death.